Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)
High and Very High Risk cardiovascular patient journeys seems to vary from country to country, and current understanding of the process is incomplete. This real-life observational study which documents meaningful patient journey-related parameters can be expected to provide meaningful insight into the care process, country-by-country.
Suffering from hypercholesterolemia is a major health concern in Europe. Appropriate medical treatment lowers low density lipoprotein cholesterol and reduces the incidence of clinical cardiovascular events. Despite the multiple available treatments, many patients remain inadequately treated or even untreated and some lipid-lowering drugs may be associated with an increase in events like side effects or increase in diabetes. As this is a non-interventional study, only data from routine clinical practice will be documented.
Inclusion Criteria:
Exclusion Criteria:
Glostrup Municipality, 2600, Denmark
Dresden, 01099, Germany
Kornwestheim, 70806, Germany
Mühlheim, 45468, Germany
Nuremberg, 90402, Germany
Chieti, Abruzzo 66013, Italy
Caserta, Campania 81100, Italy
Bologna, Emilia-Romagna 40138, Italy
Ferrara, Emilia-Romagna 44124, Italy
Reggio Emilia, Emilia-Romagna 42123, Italy
Brescia, Lombardy 25123, Italy
Milan, Lombardy 20141, Italy
Asti, Piedmont 14100, Italy
Sassari, Sardinia 07100, Italy
Prato, Tuscany 59100, Italy
Siena, Tuscany 53100, Italy
Colloto, Castille and León 33010, Spain